1Foy E,Li K,Wang C,et al.Regulation of interferon regulatory factor-3by the hepatitis C virus serine protease.Science,2003,300:1145-1148.
2Steinkuhler C,Biasiol G,Brunetti M,et al.Product inhibition of the hepatitis C virus NS3 protease.Biochemistry,1998,37:8899-8905.
3Moradpour D,Bieck E,Hugle T,et al.Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase.J Biol Chem,2002,277:593-601.
4Migliaccio G,Tomassini JE,Carroll SS,et al.Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro.J Biol Chem,2003,278:49164-49170.
5Love RA,Parge HE,Yu X,et al.Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme.J Virol,2003,77:7575-7581.
6McHutchison JG,Patel K,Pockros P,et al.A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803),administered to chronic hepatitis C patients.J Hepatol,2006,44:88-96.
7Fire A,Xu S,Montgomery MK,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.Nature,1998,391:806-811.
8Lindenbach BD,Evans MJ,Syder AJ,et al.Complete replication of hepatitis C virus in cell culture.Science,2005,309:623-626.
